tiprankstipranks
Trending News
More News >
Corteva (CTVA)
:CTVA
Advertisement

Corteva (CTVA) AI Stock Analysis

Compare
1,690 Followers

Top Page

CTVA

Corteva

(NYSE:CTVA)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 4o)
Rating:75Outperform
Price Target:
$72.00
▲(8.21% Upside)
Corteva's overall stock score of 75 reflects its strong financial performance and positive earnings call, which highlight robust growth and strategic advancements. However, the high valuation and mixed technical indicators suggest caution. The company's ability to manage competitive pressures and leverage its strategic initiatives will be key to future performance.
Positive Factors
Revenue Growth
The strong EBITDA growth in key segments indicates robust demand and effective execution, supporting long-term revenue expansion.
Innovation and Product Development
Continuous innovation, such as new product launches, strengthens Corteva's competitive position and drives future growth.
Financial Guidance
Raising financial guidance reflects management's confidence in strategic execution and market conditions, indicating strong future performance.
Negative Factors
Competitive Pricing Pressures
Persistent pricing pressures can erode margins and profitability, challenging Corteva's ability to maintain competitive advantage.
Debt Increase
Rising debt levels may constrain financial flexibility and increase risk, potentially impacting long-term financial health.
Credit Challenges in Latin America
Credit challenges in key markets like Latin America can affect sales and cash flow, posing risks to regional growth and stability.

Corteva (CTVA) vs. SPDR S&P 500 ETF (SPY)

Corteva Business Overview & Revenue Model

Company DescriptionCorteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
How the Company Makes MoneyCorteva generates revenue primarily through the sale of its seed and crop protection products. The Seed segment includes genetically modified seeds, conventional seeds, and seed treatment products, which are sold to farmers and agricultural distributors. The Crop Protection segment focuses on chemical products such as herbicides, insecticides, and fungicides that help protect crops from pests and diseases. Significant revenue streams come from both North America and international markets, with the company leveraging its research and development capabilities to introduce new and improved products. Additionally, Corteva benefits from partnerships with agricultural retailers and distributors, enhancing its market reach and access to farmers. The company also engages in sustainability initiatives and precision agriculture, which may further drive sales as demand grows for environmentally friendly and efficient farming solutions.

Corteva Key Performance Indicators (KPIs)

Any
Any
Seed Sales by Segment
Seed Sales by Segment
Tracks revenue from seed sales across various segments, indicating market demand and competitive positioning in the agriculture sector.
Chart InsightsCorteva's seed sales show robust growth in corn and soybean segments, with corn sales peaking in Q2 2024. The company anticipates a 5% increase in U.S. corn planting, aligning with their strategic focus on new seed products. Despite tariff and currency challenges, Corteva's operational excellence and cost management have led to significant margin expansion. The introduction of 500 new seed products is expected to sustain growth, while high single-digit volume gains in crop protection will mitigate pricing pressures. The overall outlook remains positive, driven by strong demand and strategic initiatives.
Data provided by:The Fly

Corteva Earnings Call Summary

Earnings Call Date:Nov 04, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 04, 2026
Earnings Call Sentiment Positive
The earnings call presented a strong performance for Corteva with positive growth metrics across both Seed and Crop Protection segments. The company successfully raised its financial guidance, reflecting confidence in its strategic initiatives. However, ongoing competitive pricing pressures in Crop Protection and credit challenges in Latin America indicate areas of concern. Overall, positive achievements and strategic advancements outweigh the challenges mentioned.
Q3-2025 Updates
Positive Updates
Strong Third Quarter Results
Corteva achieved double-digit operating EBITDA gains in both Seed and Crop Protection businesses, with expectations to deliver over $600 million in controllable benefits for the year, an increase from the previous estimate of $530 million.
Seed Business Performance
The Seed business showed strong performance with $200 million in productivity and deflation benefits, alongside $90 million in royalty improvement. Notably, Corteva has achieved price capture and share gains in North America, with expectations of crossing double-digit trade penetration for Conkesta in Brazil next year.
Crop Protection Growth
The Crop Protection segment experienced solid earnings and margin growth, with full-year EBITDA expected to rise by high single digits. The introduction of a new insecticide active, Varpelgo, highlights the company's commitment to innovation.
Raised Financial Guidance
Corteva raised its full-year operating EBITDA range to $3.8 billion to $3.9 billion, translating to a 14% growth versus the previous year. The company also expects a free cash flow conversion rate of approximately 50%.
Negative Updates
Competitive Pricing Dynamics in Crop Protection
The Crop Protection market continues to face competitive pricing pressures, particularly in Brazil, which is expected to impact overall market pricing stability.
Credit Market Challenges in Latin America
The company acknowledged increased borrowing costs and leverage among customers in Latin America, highlighting the importance of their risk management strategies to mitigate potential exposure.
Company Guidance
In the Corteva Agriscience Third Quarter 2025 Earnings Call, the company provided robust guidance, highlighting several key metrics. Corteva raised its full-year operating EBITDA range to $3.8 billion to $3.9 billion, indicating a 14% growth at the midpoint compared to the previous year. The company also increased its operating EPS guidance to $3.25 to $3.35 per share, representing a 28% increase at the midpoint. Furthermore, Corteva anticipates an EBITDA margin expansion of approximately 165 basis points. The company expects to achieve over $600 million in controllable benefits in 2025, an improvement from its previous estimate of $530 million. Additionally, Corteva projects a free cash flow conversion rate of about 50% for the year, with $1 billion in share repurchases planned. Looking ahead to 2026, the company anticipates mid-single-digit growth in operating EBITDA, targeting $4.1 billion, driven by continued innovation and productivity benefits.

Corteva Financial Statement Overview

Summary
Corteva demonstrates strong financial health with improving profitability and efficient cash flow management. The company maintains a solid balance sheet with low leverage, although the increase in debt warrants monitoring. The positive trends in revenue and profit margins, coupled with robust cash flow generation, position Corteva well for future growth in the agricultural inputs industry.
Income Statement
85
Very Positive
Corteva's income statement reflects strong profitability with a consistent gross profit margin around 46% in the TTM period. The net profit margin has improved to 9.19% from previous years, indicating enhanced efficiency. Revenue growth is modest at 1.7% in the TTM, but it shows a recovery from a slight decline in previous years. EBIT and EBITDA margins have also improved, suggesting better operational performance.
Balance Sheet
78
Positive
The balance sheet is robust with a low debt-to-equity ratio of 0.17 in the TTM, indicating conservative leverage. Return on equity has improved to 5.68%, showing better utilization of equity. The equity ratio remains strong, reflecting a solid capital structure. However, the increase in total debt over the years could be a potential risk if not managed carefully.
Cash Flow
82
Very Positive
Corteva's cash flow statement shows a healthy free cash flow growth rate of 2.31% in the TTM, with a strong free cash flow to net income ratio of 0.83. The operating cash flow to net income ratio is stable, indicating efficient cash generation relative to net income. The company has consistently improved its cash flow metrics, supporting its financial flexibility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue17.47B16.91B17.23B17.45B15.65B14.22B
Gross Profit8.05B7.38B7.31B7.02B6.43B5.71B
EBITDA3.70B2.73B2.54B2.73B3.62B1.90B
Net Income1.60B907.00M735.00M1.15B1.76B681.00M
Balance Sheet
Total Assets42.20B40.83B43.00B42.62B42.34B42.65B
Cash, Cash Equivalents and Short-Term Investments2.59B3.17B2.74B3.31B4.54B3.79B
Total Debt4.37B2.70B2.49B1.31B1.12B1.11B
Total Liabilities16.74B16.80B17.72B17.08B16.72B17.59B
Stockholders Equity25.22B23.79B25.04B25.30B25.38B24.82B
Cash Flow
Free Cash Flow2.65B1.55B1.17B267.00M2.15B1.59B
Operating Cash Flow3.20B2.15B1.77B872.00M2.73B2.06B
Investing Cash Flow-478.00M-589.00M-1.99B-632.00M-362.00M-674.00M
Financing Cash Flow-2.78B-1.20B-99.00M-1.18B-1.27B303.00M

Corteva Technical Analysis

Technical Analysis Sentiment
Positive
Last Price66.54
Price Trends
50DMA
64.31
Positive
100DMA
68.25
Negative
200DMA
66.79
Negative
Market Momentum
MACD
0.62
Negative
RSI
58.80
Neutral
STOCH
81.58
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTVA, the sentiment is Positive. The current price of 66.54 is above the 20-day moving average (MA) of 64.88, above the 50-day MA of 64.31, and below the 200-day MA of 66.79, indicating a neutral trend. The MACD of 0.62 indicates Negative momentum. The RSI at 58.80 is Neutral, neither overbought nor oversold. The STOCH value of 81.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CTVA.

Corteva Risk Analysis

Corteva disclosed 31 risk factors in its most recent earnings report. Corteva reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Corteva Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$44.96B28.416.73%1.05%5.00%136.31%
72
Outperform
$12.45B9.6227.46%2.51%12.59%31.40%
65
Neutral
$7.77B6.3510.00%3.55%3.82%239.39%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
$7.36B20.046.15%3.12%1.77%-8.72%
54
Neutral
$3.28B22.894.63%-3.93%
48
Neutral
$1.73B-11.52%16.76%-13.42%-136.59%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CTVA
Corteva
66.54
5.99
9.89%
CF
Cf Industries Holdings
78.97
-10.38
-11.62%
FMC
FMC
13.84
-41.90
-75.17%
MOS
Mosaic Co
24.96
-0.97
-3.74%
SMG
Scotts Miracle-Gro Company
56.99
-15.63
-21.52%
ICL
Icl
5.57
0.66
13.44%

Corteva Corporate Events

Corteva’s Strong Q3 Performance Boosts 2025 Outlook
Nov 6, 2025

Corteva, Inc. is a global agriculture company that specializes in seed and crop protection products, leveraging innovative technology and a diverse product portfolio to address agricultural challenges worldwide.

Corteva’s Earnings Call: Strong Growth and Raised Guidance
Nov 6, 2025

Corteva’s recent earnings call showcased a strong performance, with positive growth metrics across its Seed and Crop Protection segments. The company expressed confidence in its strategic initiatives by raising its financial guidance. Despite facing competitive pricing pressures in Crop Protection and credit challenges in Latin America, the positive achievements and strategic advancements were highlighted as outweighing these concerns.

Business Operations and StrategyExecutive/Board Changes
Corteva Appoints New Chief Legal Officer
Neutral
Aug 26, 2025

On August 26, 2025, Corteva announced the appointment of Jennifer Johnson as the new chief legal officer, effective September 15, 2025. She will succeed Cornel Fuerer, who will transition to a strategic advisor role before retiring in 2026. Johnson brings extensive experience from her previous roles at International Flavors & Fragrances and DuPont, where she focused on legal, commercial, and intellectual property strategies. This leadership change is expected to support Corteva’s strategic goals and strengthen its legal operations as it continues to innovate in the agriculture sector.

The most recent analyst rating on (CTVA) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on Corteva stock, see the CTVA Stock Forecast page.

Corteva Reports Strong 2025 Earnings, Raises Guidance
Aug 8, 2025

Corteva, Inc. is a global agriculture company specializing in seeds, crop protection, and digital solutions, aiming to address pressing agricultural challenges with innovative products and services. In its latest earnings report, Corteva announced a robust financial performance for the first half of 2025, leading to an upward revision of its full-year guidance. The company reported a 3% increase in net sales and a 5% rise in organic sales compared to the previous year, driven by strong demand in North America and EMEA regions. Key financial metrics showed significant improvements, with GAAP income from continuing operations reaching $2.05 billion and operating EBITDA rising to $3.35 billion. Corteva’s strategic focus on cost management and operational excellence contributed to these positive results. Looking ahead, Corteva is optimistic about its growth prospects, with expectations of continued demand for its products and a strong setup for its Latin American business in the second half of the year.

Corteva Earnings Call Highlights Robust Growth Amid Challenges
Aug 8, 2025

Corteva’s recent earnings call painted a largely positive picture, highlighting robust financial performance and strategic gains across its core business segments. The company showcased notable achievements in both the Seed and Crop Protection areas, alongside effective cost management strategies. However, it also acknowledged challenges such as pricing pressures and currency headwinds, particularly impacting the Crop Protection segment.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025